From Early Discovery to Late-Phase Studies: Advancing Oncology with MAA Technology

MAA (Molecular Affinity Analysis) is a platform for in situ detection and quantification of therapeutic binding sites on patient tumor tissue. It enables precise assessment of target accessibility, binding site density, and spatial distribution, providing valuable insights for biomarker validation, patient stratification, and therapy optimization. MAA is compatible with a wide range of therapeutics, including small molecules, monoclonal antibodies, bispecific antibodies, ADCs, radioligands, and CAR-T cell targets, making it a versatile approach for advancing precision oncology.


 

Specific Examples of MAA Applications by Stage

MAA offers a wide range of applications across the drug development lifecycle. Here are just a few examples of how MAA can support different stages:


  • Preclinical Development: MAA-Based Preclinical Tumor Profiling - Detect therapeutically relevant regions to validate therapeutic target accessibility and binding site density in preclinical models or primary tumor samples to guide your clinical trial design.
  • Clinical Trials: MAA-Based Clinical Trial Stratification - Stratify patients based on the presence and accessibility of drug targets in tumor tissues to support the enrichment of trial populations pro- or retrospectively.
  • Post-Marketing: MAA-Based Personalized Therapy Identification - Use MAA to assess drug-target interactions in tumor samples from patients with recurrent or refractory disease, supporting the exploration of tailored treatment options and new therapeutic opportunities.

Partner with Us to Advance Precision Oncology

We invite you to connect with us to explore how our Molecular Affinity Analysis (MAA) platform can address your research and clinical objectives. Whether your focus is on enhancing clinical trial strategies, or advancing therapeutic profiling, our team is ready to provide tailored support and expert guidance.


Contact us to discuss your specific needs, request detailed information, or learn more about how MAA technology can contribute to your success in drug development and precision oncology.